CancerVax Presents Preclinical Data Demonstrating Tumor Inhibition by D93, a Novel Anti-Angiogenic Monoclonal Antibody; Data Presented at AACR Annual Meeting
In: Internet Wire, 2006-04-04
Zeitungsartikel
Zugriff:
CARLSBAD, CA, Apr 04, 2006 (MARKET WIRE via COMTEX) -- CancerVax Corporation (NASDAQ: CNVX) announced today that its wholly owned subsidiary, Cell-Matrix, Inc., presented preclinical data indicating that D93, the [...]
Titel: |
CancerVax Presents Preclinical Data Demonstrating Tumor Inhibition by D93, a Novel Anti-Angiogenic Monoclonal Antibody; Data Presented at AACR Annual Meeting
|
---|---|
Zeitschrift: | Internet Wire, 2006-04-04 |
Veröffentlichung: | 2006 |
Medientyp: | Zeitungsartikel |
Schlagwort: |
|
Sonstiges: |
|